Abstract
Five lines of human breast-carcinoma xenografts have been tested for sensitivity to cyclophosphamide, methotrexate, 5-fluorouracil, adriamycin, vincristine and melphalan, alone and in combination, using tumour growth delay as an end-point. The xenograft lines were established and passaged in mice immune-suppressed by thymectomy and whole-body irradiation. There was a considerable range of sensitivity of the different lines to the agents studied, and within this variation there was evidence that the most effective single agent or combination differed for each tumour. Combination chemotherapy was more effective than single agents in 3 of the lines, but melphalan was more effective than either combination in the other 2. It is suggested that a panel of human breast tumours grown in immune-suppressed mice may prove useful in testing new cytotoxic agents for activity against breast cancer before their use in clinical trials, and that more effective combinations of existing drugs might be designed with the aid of this system.
Full text
PDF






Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bailey M. J., Gazet J. C., Peckham M. J. Human breast-cancer xenografts in immune-suppressed mice. Br J Cancer. 1980 Oct;42(4):524–529. doi: 10.1038/bjc.1980.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bonadonna G. Adjuvant chemotherapy of breast cancer. Br J Hosp Med. 1980 Jan;23(1):40–passim. [PubMed] [Google Scholar]
- Brambilla C., De Lena M., Rossi A., Valagussa P., Bonadonna G. Response and survival in advanced breast cancer after two non-cross-resistant combinations. Br Med J. 1976 Apr 3;1(6013):801–804. doi: 10.1136/bmj.1.6013.801. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carter S. K. Integration of chemotherapy into combined modality treatment of solid tumors VII. Adenocarcinoma of the breast. Cancer Treat Rev. 1976 Sep;3(3):141–174. doi: 10.1016/s0305-7372(76)80020-5. [DOI] [PubMed] [Google Scholar]
- Shimosato Y., Kameya T., Nagai K., Hirohashi S., Koide T., Hayashi H., Nomura T. Transplantation of human tumors in nude mice. J Natl Cancer Inst. 1976 Jun;56(6):1251–1260. doi: 10.1093/jnci/56.6.1251. [DOI] [PubMed] [Google Scholar]
- Shorthouse A. J., Peckham M. J., Smyth J. F., Steel G. G. The therapeutic response of bronchial carcinoma xenografts: a direct patient-xenograft comparison. Br J Cancer Suppl. 1980 Apr;4:142–145. [PMC free article] [PubMed] [Google Scholar]
- Steel G. G., Courtenay V. D., Rostom A. Y. Improved immune-suppression techniques for the exongrafting of human tumours. Br J Cancer. 1978 Feb;37(2):224–230. doi: 10.1038/bjc.1978.30. [DOI] [PMC free article] [PubMed] [Google Scholar]